CIAM
ARCT icon

Caitong International Asset Management’s Arcturus Therapeutics ARCT Stock Holding History

Caitong International Asset Management’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.9K Buy
+1,023
New +$7.46K ﹤0.01% 1101
2025
Q3 		– Sell
-158
Closed -$2.06K – 1935
2025
Q2 		$2.06K Buy
+158
New +$1.87K ﹤0.01% 1375
2025
Q1 		– Sell
-28
Closed -$475 – 2158
2024
Q4 		$475 Buy
+28
New +$527 ﹤0.01% 1478

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Caitong International Asset Management's ARCT Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in Arcturus Therapeutics (ARCT) in Q1 2026: 1,023 shares worth $7.9K. The stake represents ﹤0.01% of the portfolio and ranks #1101 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in ARCT as recently as Q2 2025.

Caitong International Asset Management first reported a position in ARCT in Q4 2024 and has held it in 3 quarters since. 124 funds tracked by Wall St. Rank hold ARCT as of Q1 2026.

  • Caitong International Asset Management held 1,023 shares of Arcturus Therapeutics worth $7.9K as of Q1 2026.
  • Arcturus Therapeutics was a new Caitong International Asset Management position in Q1 2026.
  • Arcturus Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #1101 holding.
  • Caitong International Asset Management first reported a position in Arcturus Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • 124 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.